2016 Price Target (Generous) :
Reduced to $11
Since our first report, Mobileye’s (NASDAQ:MBLY) long-term prospects have gone from bad to worse. Insiders know it, Goldman Sachs definitely knows it … because at the end of the day,
In this report, we detail critical competitive landscape changes since our last report that the market has not priced in yet, but are hiding in plain sight. Then Citron Research offers up the only intellectually honest way to value Mobileye.
It May Jump but It Will Never Fly.